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Objective
Percutaneous transluminal angioplasty (PTA) of crural arteries remains a valuable procedure for limb salvage in critical limb 
ischemia (CLI). Patients with anatomically unfavourable occlusive lesions of infrapopliteal arteries are usually offered a bypass 
surgery. The aims of this study were to report our experience, compare long-term results of surgical revascularization of pedal 
arteries and infrapopliteal PTA in patients with CLI, and assess the impact of diabetes mellitus and the type of treatment on 
limb salvage rates.
Methods
All tibial interventions to treat CLI, which were performed during the period of January 1999 to December 2013, were retro-
spectively analysed. The outcomes of tibial PTA procedures and open surgery – bypasses to dorsal pedal artery (DP) – were 
compared. The impact of diabetes mellitus control on the primary revascularization procedures’ outcomes was analysed.
Results
Three patient groups were formed: the open repair group (treated by dorsal pedal artery bypass operation) – 193 patients, 
the endovascular repair group – 103 limbs in 98 patients, and the combined treatment group (endovascular repair and dorsal 
pedal artery bypass) – 84 patients. The cumulative patency rate in the open repair group at a 1-year period was 47.5%, in the 
endovascular repair group – 6.9% and in the combined treatment group – 79.6%. The best results of revascularization were 
achieved in the combined treatment group (p < 0.007). The limb salvage rate at the 1-year follow-up was 84.1% in the open 
repair group, 35.4% in the endovascular repair group, and 83.1% in the combined treatment group. In the combined treat-
ment group, limbs were saved for a longer period (p < 0.01). The patency rates for DP artery bypasses at the 1-year follow-up 
in diabetic patients were 60.4%, in non-diabetic patients – 21.8% (p = 0.013), and for PTA procedures in diabetic patients – 
3.6%, in non-diabetic – 10.1%. The patency rate in patients under tight plasma glucose control was 55.2%, in uncontrolled 
diabetes group – 43.6% after two years. The limb salvage rate in patients under a tight plasma glucose control was 79.31%, in 
uncontrolled diabetes group – 61.82% after two years. These findings had no significance (p > 0.05).
Originalūs mokslo tiriamieji darbai
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Conclusion
Both infrapopliteal angioplasty and bypass surgery provide an acceptable limb salvage rate, but the follow-up patency ap-
pears to be better after bypass surgery. The duration of revascularization in the open repair group was longer as compared 
to the endovascular repair group. The best revascularization results were in diabetic patients after open surgery combined 
with PTA (combined treatment group). DP artery bypass is a safe and durable procedure in patients with CLI and patients with 
diabetes mellitus. Tight plasma glucose levels control has no effect on primary revascularization outcomes.
Key words: percutaneous transluminal angioplasty (PTA), dorsalis pedis artery (DP) bypass, critical limb ischemia, diabetes mellitus
Įvadas/tikslas
Blauzdos arterijų angioplastika yra vertinga galūnės išsaugojimo procedūra ligoniams, sergantiems kritine kojų išemija. Esant 
blauzdos arterijų užakimui, dažniausiai atliekama arterijų šuntavimo operacija. Šio tyrimo tikslas buvo parodyti mūsų gydymo 
rezultatus bei palyginti arterijų šuntavimo operacijų į pėdos arteriją ir blauzdos arterijų perkutaninės transliuminalinės an-
gioplastikos vėlyvuosius rezultatus esant kritinei kojos išemijai. Taip pat įvertinti cukrinio diabeto įtaką operacijų rezultatams. 
Metodai
Retrospektyviuoju būdu išanalizuotos visos gydomosios blauzdos arterijų procedūros, atliktos nuo 1999 m. sausio iki 2013 m. 
gruodžio mėnesio. Buvo palyginti blauzdos arterijų perkutaninės transliuminalinės angioplastikos ir atviros chirurgijos – šun-
tų į pėdos arteriją gydymo rezultatai. Išanalizuota cukrinio diabeto įtaka gydymo rezultatams. 
Rezultatai
Sudarytos trys pacientų grupės: I grupė – 193 ligoniai, kuriems atliktos šuntavimo į pėdos arteriją operacijos; II grupė – 103 
atvejai 98 pacientams, kuriems atlikta blauzdos arterijų perkutaninė transliuminalinė angioplastika; III grupė – 84 pacientai, 
kuriems taikytas sudėtinis gydymas – perkutaninė transliuminalinė angioplastika ir šuntavimas į pėdos arteriją. Kumuliacinis 
kraujotakos atkūrimas po 1 metų atlikus atvirą operaciją – 47,5 %, atlikus blauzdos arterijų angioplastiką – 6,9 %, atlikus sudėti-
nį gydymą – 79,6 %. Geriausi rezultatai gauti sudėtinio gydymo grupėje (p<0,007). Galūnės išsaugojimas po vienų metų atlikus 
operaciją – 84,1 %, po endovaskulinės chirurgijos – 35,4 %, po sudėtinio gydymo – 83,1 %. Ilgesnį laikotarpį galūnės išsaugotos 
po sudėtinio chirurginio gydymo (p<0,001). Cukriniu diabetu segantiems ligoniams kumuliacinis kraujotakos atkūrimas praė-
jus vieniems metams po šuntavimo į pėdos arteriją operacijų – 60,4 %, nesergantiems cukriniu diabetu – 21,8 % (p=0,013), po 
atliktos blauzdos arterijų angioplastikos cukriniu diabetu sergantiems ligoniams – 3,6 %, nesergantiems – 10,1 %. Kumuliacinis 
kraujotakos atkūrimas, praėjus dvejiems metams po rekonstrukcinių procedūrų, jei cukrinis diabetas kompensuotas, sudarė 
55,2 %, o jei nekompensuotas – 43,6 %. Galūnės išsaugojimas esant kompensuotam cukriniam diabetui sudarė 79,31 %, o 
nekompensuotam – 61,82 %. Rezultatas nėra statistiškai patikimas (p>0,05).
Išvados
Blauzdos arterijų angioplastika ir šuntavimo operacija yra tinkamos procedūros išsaugoti galūnę ligoniams, sergantiems kri-
tine galūnės išemija. Vėlyvieji kraujotakos atkūrimo rezultatai buvo geresni po šuntavimo į pėdos arteriją atliktų operacijų. 
Geriausi kraujotakos atkūrimo rezultatai ligoniams, sergantiems cukriniu diabetu, pasiekti taikant sudėtinį gydymo metodą – 
angioplastiką ir atvirą operaciją. Šuntavimas į pėdos arteriją yra saugi ir efektyvi procedūra cukriniu diabetu sergantiems 
pacientams, turintiems kritinę kojos išemiją. Glikozilinto hemoglobino kiekis neturi įtakos kraujotakos atkūrimo rezultatams. 
Reikšminiai žodžiai: perkutaninė transliuminalinė angioplastika (PTA), šuntas į nugarinę pėdos arteriją, kritinė kojos išemija, 
cukrinis diabetas 
Introduction
Critical limb ischemia (CLI) describes a condition when 
the peripheral artery disease has progressed and results 
in resting leg pain or in a breakdown of the skin caus-
ing tissue loss. If not revascularized, CLI patients are at 
a risk for limb loss. The management of CLI requires 
a multidisciplinary team. Most patients with CLI have 
multisegmental lesions involving infrapopliteal arteries. 
PTA of crural arteries remains a valuable procedure for 
limb salvage in CLI. The limb salvage rate after PTA is 
higher than the angiographic patency rate. Patients with 
long lesions in infrapopliteal arteries are usually offered 
a bypass surgery [1]. Direct pedal bypass is performed 
most frequently. CLI treatment guidelines recommend 
the bypass surgery only and the use of saphenous vein 
graft only in case of long (>15 cm) lesions of the artery 
in younger and healthier patients with the life expec-
tancy of more than two years [1].
An aggressive treatment approach towards threatened 
ischemic limbs is supported by numerous studies which 
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present high limb salvage rates after revascularization 
procedures of infrapopliteal arteries. Primary major am-
putation rates decreased from 41% to 5%, and the total 
amputation rates decreased from 49% to 14% in cases 
of CLI caused by femoral, popliteal and tibial arteries 
with the occlusive disease [2]. The treatment of diabetic 
patients with chronic arterial insufciency has changed. 
The term “diabetic small vessel disease” removed such 
patients from the realm of the vascular surgeon, and 
the treatment generally involved major amputation [3, 
4, 5, 20]. Multiple reports have demonstrated similar 
patency and limb salvage rates following infrapopliteal 
reconstruction in diabetics and non-diabetics. The aim 
of this study was to assess the impact of diabetes mellitus 
on limb salvage rates in patients with CLI, to compare 
the results of infrapopliteal PTA and surgical revascular-
ization of pedal arteries, and also to report our long-term 
results and experience in these procedures. 
Patients and methods
A retrospective review of patients who were treated 
surgically and / or endovascularly due to CLI with in-
frapopliteal atherosclerotic arterial lesions from January 
1999 to December 2013 was performed. Patients with 
type 1 diabetes mellitus (due to the insufcient num-
ber of patients) or endarteritis were excluded from the 
study. A consented permission for this study was issued 
by the Vilnius Regional Biomedical Research Ethics 
Committee on January 11, 2013, permission number 
158200-13-572-167.
This study involved 296 patients – 193 patients 
had dorsal pedal artery (DP) bypass operation (open 
repair group), 103 patients underwent infrapopliteal 
PTA procedures (endovascular repair group), and 84 
patients experienced both DP bypass and PTA (com-
bined treatment group). All patients were treated for 
resting pain and gangrene in the leg. Patients were 
either at risk of imminent limb loss or had a severe 
rest pain. Non-invasive treatment methods involved 
smoking cessation and an aggressive medical treatment 
to control the present risk factors such as hypertension 
and elevated serum glucose levels. All arterial lesions 
were confirmed by conventional angiography. The 
main indication for DP bypass was the insufcient 
run-off from tibial arteries to the foot, multisegmen-
tal stenosis of tibial arteries, stable general condition 
and the absence of wounds on the predicted area of 
incision. All bypasses to the dorsal pedal artery were 
performed with an autologous vein graft. The greater 
saphenous vein was used as a conduit in 96.7% of 
the cases. The choice of the conduit and the site of 
proximal anastomosis were based on the surgeon’s 
preference. The anastomosed dorsal pedal artery had a 
direct inflow to the pedal arch in all cases. Immediate 
patency of the graft was confirmed with intraopera-
tive duplex ultrasound or angiography. All interven-
tions were performed by one team following the same 
method of reversed vein, anastomosing the DP artery 
and angioplasty. Initially, the choice for PTA as the 
therapeutic method was made for patients with TASC 
A and B lesions, technical limitations to open surgery 
(wounds near to surgical access sites and absence of 
proper vascular substitutes) or a high operative risk. 
All endovascular interventions were performed under 
local anesthesia with a 1% lidocaine solution. Lesions 
were passed with 0.018–0.035 inch guide wires. Long 
extension balloons were the treatment of choice for 
extensive lesions. When feasible, two or more infrap-
opliteal arteries were treated. Intraoperative success 
criteria were defined as residual stenotic lesions <20% 
of the adjacent normal arterial diameter with a regular 
surface and absence of any evidence of arterial dissec-
tion or distal embolization. All patients treated by PTA 
received anticoagulation therapy during the procedure 
and were prescribed aspirin and / or Clopidogrel once 
daily following their intervention. If proximal and dis-
tal stenosis were angiographically found (for example, 
stenosis in femoral and multiple stenosis in tibial 
arteries), the patient was assigned to combined treat-
ment. First, proximal stenosis was dilated and the next 
day distal bypass surgery was performed. This way the 
inflow was improved and there was no need for a long 
vein graft. Short-term results were assessed 24 hours af-
ter the procedure and on the day of discharge from the 
hospital, and long-term results were assessed 6 months, 
1 year and 2 years after the procedure. During these 
visits, blood circulation of the lower extremity was 
evaluated by the arterial-brachial index calculations 
and duplex ultrasound scanning. Angiography was 
performed only when non-invasive tests suggested a 
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significant restenosis or occlusion of the artery or the 
bypass. Success was accounted as the improved subjec-
tive condition of the patient (disappearance of rest pain, 
improved walking distance without pain, decreased 
need for pain killers), improved ankle-brachial index 
(>0.4) or successful wound healing. The amputation 
of the involved limb was performed when the revascu-
larization was not possible. The coronary artery disease 
was identified if there was a history of angina pectoris, 
myocardial infarction or prior coronary artery revascu-
larization. The cerebrovascular disease was determined 
if there was a history of stroke, transient ischemic at-
tack, or carotid artery revascularization. Hypertension 
was defined as a systolic blood pressure greater than 
140  mmHg or diastolic blood pressure greater than 
90 mmHg over a period of time or the documented 
diagnosis by a cardiologist. Chronic renal insufciency 
was defined if an impaired renal function was found 
for >3 moths based on an abnormal structure or func-
tion, or the GFR <60 mL/min/1.73 m2 was found for 
>3 months with or without evidence of kidney damage, 
and the diagnosis was documented by a nephrologist. 
Diabetes was diagnosed if fasting plasma glucose level 
was >126  mg/dL, or a 2-hour plasma glucose level 
>200 mg/dL during a 75 g oral glucose tolerance test 
or accidental plasma glucose >200 mg/dL with classic 
symptoms of diabetes, and this diagnosis was approved 
by the consulting endocrinologist or patient history 
data. We considered a well controlled Type 2  diabe-
tes when HbA1 was <7%, and the value of >7% was 
considered as uncontrolled diabetes. These distinctions 
were made in accordance with the patient history data 
and endocrinologal diagnosis. Limb ischemia was di-
agnosed if the brachial-ankle index was less than 0.5 
and / or more than 60% stenosis was found in the 
affected artery by a duplex ultrasound investigation. 
Peri-interventional morbidity included all events that 
occurred during and up to 30 days following the initial 
intervention. Systemic antibiotics were prescribed each 
time a wound infection was reported.
Statistical analysis
Providing descriptive statistics, the mean values of vari-
ous variables, their standard error, 95% CI were calcu-
lated. Based on these data, cumulative primary patency 
and limb salvage rates were calculated by Kaplan–Meier 
analysis for different patient and case groups. The results 
were presented in percent with the standard error and 
expressed by curves which were compared by the long 
rang test. Statistical significance was accepted at a level 
of p < 0.05. The statistical analysis of the results was 
performed using the program packages SPSS statistics 
17 and Microsoft Ofce Excel 2007.
Results
Epidemiological and clinical data, as well as anatomical 
and morphological characteristics of both groups are 
summarized in Table 1. The angioplasty and anatomical 
arterial sites are described in Table 2.
Table 1. Patients characteristics and stage of the disease
Demographics Open repair group Endovascular repair group Combined treatment group
Age 63 (41–85) 70 (48–91) 68 (41–86)
Male gender 84 (43.5%) 67 (65%) 23(25%)
Diabetes mellitus 131 (68%) 49 (48%) 27 (27.4%)
Hypertension 92 (47,6%) 98 (95%) 47 (56%)
Heart disease 89 (46.1%) 91 (89%) 51 (62%)
Renal insufciency
Dialysis
3 (1%)
3 (1.5%)
9 (8.7%)
7 (6.8%)
2 (2.4%)
1 (1.2%) 
Current smoker 46 (23.8%) 83 (80.6%) 58 (69%)
Indications:
Rest pain 59 (30.6%) 22 (21.4%) 36 (42.9%)
Gangrene 57 (29.5%) 88 (85.4%) 34 (40.5%)
Infection 10 (5.1%) 16 (15.5%) 7 (8.3%)
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103 endovascular procedures infrapopliteal arteries 
were performed. In 84 cases treatment of iliac, femoral, 
popliteal and tibial arteries was combined – endovascu-
lar procedures in suprapopliteal arteries and open repair 
in tibial arteries (combined treatment group). 
Intraoperative technical success was achieved in 
100 out of 103 cases in endovascular treatment group 
(95.8%). Two patients had plaque dissection followed 
by immediate thrombosis and required immediate sur-
gical intervention. One patient had distal embolization 
and thrombosis. He was treated with heparin. 
All 193 DP artery bypasses presented with 100% 
intraoperative success. Five (2.6%) bypasses stopped 
functioning in early postoperative period. They were not 
included in statistical analysis. One patient presented 
with pneumonia and six patients presented with skin 
dehiscence at the incision site. There was one periopera-
tive death related to cardiovascular event. 
The mean period of the follow-up was 17 months. 
There were some patients lost during the follow-up pe-
riod. The primary patency rate in the open repair group 
was 67.3 ± 5.4% after 6 months, 47.5 ± 8.3% after 
1 year, 27.5 ± 9% after 2 years. The primary patency 
rate in endovascular repair group was 65.5 ± 5.2% after 
6 months and 6.9 ± 4.6% after 1 year. The primary 
patency rate for the combined treatment group was 
91.5 ± 3.6% after 6 months, 79.6 ± 7.2% after 1 year 
and 73.5 ± 8.8% after 2 years (p < 0.05) 
The limb salvage rate for the open surgery group 
in the 24-month follow-up period was 81.4 ± 4.3% 
after 6 months, 68.2 ± 6.5% after 1 year, 57.5 ± 7.9% 
Table 2. Arteries treated by angioplasty and bypass graft 
surgery 
Proximal anastomosis:
Poplitea artery 38 (19.7%)
Superficial femoral artery 138 (71.5%)
Ex autovena bypass 12 (6.2%)
Tibial arteries 5 (2.6%)
Distal anastomosis:
Dorsal pedis artery 193 (100%)
PTA anterior tibial artery 62 (60.2%)
PTA posterior tibial artery 7 (6. 8%)
PTA fibular artery
PTA iliac artery 
34 (33.0%)
23 (27.4%)
PTA superficial femoral artery 54 (64.3%)
PTA popliteal artery above knee 5 (5.9%)
PTA popliteal artery below knee 2 (2.4%)
Fig. 1. Kaplan–Meier life-table analysis (long-rank test) of 
function rates in open surgery and percutaneous transluminal 
angioplasty in infrapopliteal arteries. Primary patency
Autovena to ADP
PTA
Composite
Days
Fig. 2. Kaplan–Meier life-table analysis (long-rank test) of 
function rates in open surgery and percutaneous transluminal 
angioplasty in infrapopliteal arteries. Limb salvage
Autovena to ADP
PTA
Composite
Days
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after 2 years, for the PTA group – 74.8 ± 5.4% after 
6 months, 35.4 ± 1.2% after 1 year, in combined treat-
ment group – 95.2 ± 2.7% after 6 months, 83.1 ± 6.1% 
after 1 year, 83.1 ± 6.1% after 2 years. The difference 
between the limb salvage rate of combined treatment 
and only open surgery or only PTA was statistically 
significant (p = 0.03).
In the diabetic patients group, the primary patency rate 
in the open repair group was 72.5 ± 6.0% after 6 months, 
60.4 ± 9.3% after 1 year, 36.2 ± 1.2% after 2 years, in the 
endovascular repair group 60.5 ± 7.5% after 6 months, 
3.6 ± 4.9% after 1 year, in the combined treatment group 
91.1 ± 4.2% after 6 months, 81.0 ± 0.7% after 1 year, 
72.9 ± 1.0% after 2 years.
Fig. 3. Diabetic patients: primary patency Fig. 4. Diabetic patients: limb salvage
Autovena to ADP
PTA
Composite
Autovena to ADP
PTA
Composite
DaysDays
Fig. 5. Non-diabetic patients: primary patency Fig. 6. Non-diabetic patients: limb salvage
Autovena to ADP
PTA
Composite
Autovena to ADP
PTA
Composite
Days Days
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In the non-diabetic patients group, the primary pa-
tency rate in open repair group was 54.5 ± 10.6% after 
6 months, 21.8 ± 12.7% after 1 year, 10.9 ± 10.0% after 
2 years, in the endovascular repair group 70.7 ± 7.1% af-
ter 6 months, 10.1 ± 7.7% after 1 year; in the combined 
treatment group 92.9 ± 6.9% after 6 months, 74.3 ± 1.7% 
after 1 year, 46.6 ± 1.7% after 2 years.
Statistically, primary patency was better in open 
surgery or combined treatment in diabetic patients 
(p < 0.05), but in non-diabetic patients the results were 
better in the PTA group (p < 0.05).
The limb salvage rate for diabetic patients: in the 
open surgery group 84.5 ± 4.8% after 6 months, 80.6 ± 
5.9% after 1 year, 69.9 ± 8.7% after 2 years, in the PTA 
group 68.1 ± 7.9% after 6 months, 27.2 ± 1.5% after 
1 year in the combined treatment group 95.7 ± 2.9% 
after, 6 months, 87.2 ± 6.3% after 1 year, 87.2 ± 6.3% 
after 2 years. 
The limb salvage rate in non-diabetic patients: treated 
by open repair – 73.3 ± 9.3% after 6 months, 40.7 ± 
13.2% after 1 year, 30.6 ± 13.3% after 2 years, treated 
endovascularly – 82.8 ± 7.0% after 6 months, 46.0 ± 
1.9% after 1 year, in the combined treatment group – 
93.8 ± 6.1% after 6 months, 72.9 ± 13.8% after 1 year, 
72.9 ± 13.8% after 2 years. 
Statistically, the limb salvage rate in diabetic patients 
was better in the open surgery and in the combined 
treatment groups (p < 0.05). 
In the PTA group, the result was better for non-
diabetic patients (p < 0.05).
Primary patency rates and limb salvage rates were 
compared among patients whose plasma glucose levels 
were well controlled and uncontrolled according to 
HbA1 levels. 84 patients were included in this com-
parison. 29 had well-controlled diabetes and 55 had 
unctontrolled diabetes. 
The primary patency rate after two years in the well-
controlled diabetes group was 55.2% (16 grafts with 
primary patency vs. 13 trombosed grafts), in the uncon-
trolled diabetes group – 43.6% (24 grafts with primary 
patency vs. 31 trombosed grafts). Statistically, primary 
patency rates between these two groups are insignificant 
(p > 0.05).
The limb salvage rate after two years in the well-con-
trolled diabetes group was 79.31% (6 amputated limbs), 
in uncontrolled diabetes group – 61.82% (21 limb lost).
Statistically, limb salvage rates between these two 
groups are insignificant (p > 0.05).
Well controlled DM
Uncontrolled DM
Fig. 7. Well controlled diabetes vs. uncontrolled diabetes 
primary patency
Fig. 8. Well controlled diabetes vs. uncontrolled diabetes limb 
salvage
Well controlled DM
Uncontrolled DM
156 A .  N a v i c k i e n ė ,  U .  B u i l y t ė ,  G .  K a l i n a u s k a s
Discussion 
During the last decade, the frequency of endovascular 
treatment for the arterial occlusive disease has increased, 
even in the infrapopliteal segment. Low rates of early 
morbidity have been considered as an advantage of PTA 
compared to bypass surgery in the management of limb 
ischemia. The comparison of surgical and endovascular 
techniques in randomized controlled trials is almost im-
possible due to difculties in forming comparable groups. 
Moreover, in retrospective studies, the patient character-
istics for surgical and endovascular groups may differ sig-
nificantly. In order to avoid the difculties of comparing, 
the propensity score analysis may be used to adjust for 
such important differences. Our propensity score analy-
sis included preoperative risk factors, indications for the 
procedure as well as leg status, target segment, previous 
revascularization procedure on the same segment, and 
patent target vessel down to the pedal artery. In the overall 
series and in the propensity score, matched pairs PTA 
and bypass surgery achieved similar 6 months leg salvage, 
survival and amputation-free survival rates. Both provide 
an acceptable limb salvage rate, but patency appears to be 
better after bypass surgery [1, 9, 15]. The greatest problem 
in treating lower limb ischaemia and trying to compare 
different methods of treatment is that it is very difcult 
to standardize the disease itself. Even when the propen-
sity score analysis is applied, the comparison of bypass 
and PTA still faces a problem – the type of the treated 
lesion and the extent of arterial disease were not taken 
into account due to the lack of a proper classification of 
infrapopliteal lesions. There is a number of infrainguinal 
arterial lesions that cannot be easily classified, and the 
current classification systems are reported to have a poor 
reproducibility. Moreover, endovascular interventions are 
much more likely to be performed for stenotic segments 
than occlusions. As bypass surgery is particularly suitable 
for longer lesions, the incomparability of the treated seg-
ments may have influenced the present results. As previ-
ous randomized trials have demonstrated, only 4–29% 
of the lesions have been treated by either method which 
worsens the generalizability of the findings of randomized 
controlled trials [31].
The recent development of specific devices and 
techniques designed for the management of long exten-
sion lesions in infrapopliteal vessels has provided the 
opportunity to manage long stenosis or occlusions in 
tibial vessels by endovascular methods. PTA is a good 
treatment option for older patients who have higher 
operative risks and a shorter life expectancy [10, 17, 
20, 21]. There is an increasing number of patients un-
dergoing PTA instead of surgery with long tibial artery 
lesions and the multisegmental disease. A lot of research 
into arterial stenosis or occlusion treatment have been 
focused on the outcomes of endoluminal interventions. 
But the majority of them have relayed on short-term re-
sults only. Our study suggests that angioplasty provides 
an acceptable short-term limb salvage rate. Nevertheless, 
the goals for CLI treatment include the inline flow to 
the foot arteries to assist wound healing, rest pain relief, 
short-term morbidity, major amputation prevention, as 
well as patient function and life quality improvement. 
Patients with diabetic foot ulcers and concomitant 
PAD are at a higher risk for limb loss and premature 
death. In our study, better results following PTA were 
shown in non-diabetic patients, possibly due to diabetic 
patients’ arterial calcinosis and the lack of the pedal arch. 
However, when the patient clinical status is complicated 
by the presence of wound infection and diabetes, endo-
vascular reconstruction is preferred [8, 18]. 
This study shows that the DP artery bypass for foot 
ischemia in diabetic patients is a safe, effective and 
durable procedure. Graft patency and limb salvage 
rates are comparable with more proximal infrainguinal 
arterial reconstructions and when performed with the 
autologous saphenous vein have an excellent durability 
with patency for 2 years or longer [24, 25, 26]. Pedal 
bypass is well suited to the anatomic pattern of athero-
sclerosis most commonly seen in patients with diabetes 
mellitus [10, 14, 28]. For many patients, dorsal pedal 
artery may be the only outflow target artery available for 
the bypass and should always be included in the preop-
erative arteriogram. Angiography and duplex scanning 
play an important role in assessing these patients. Foot 
angiographies are a useful adjunct in demonstrating the 
patency of such vessels and in planning surgery [16].
The use of DP bypass revascularization has reduced 
the primary amputation rate, especially in diabetic 
patients [11, 12, 13 16, 22, 23, 29, 30]. This study 
confirms that DP artery bypasses can be durable not 
only in diabetic but also in non-diabetic population. 
157Comparison of outcome after infrapopliteal angioplasty and pedal bypass surgery
The long-term patency appears to be better after open 
surgery. The duration of the revascularization effect after 
open surgery was longer as compared with PTA. Normal 
rates of limb salvage can be achieved in patients with 
critical limb ischemia undergoing multilevel interven-
tions [7]. In our study, the best results of revasculariza-
tion, especially in diabetic patients, were achieved in the 
combined treatment group (open repair + endovascular 
treatment). Dorsal pedal artery bypass results, especially 
combined with PTA (in order to shorten the bypass) 
and with good inflow, are rather promising despite the 
limited distal vascular bed. This kind of revasculariza-
tion procedure has advantages over the more proximal 
infrapopliteal bypass, especially for diabetic patients 
whose estimated life expectancy is over two years [27]. 
One of our research questions was to assess the impact 
of diabetes mellitus on limb salvage rates in patients 
with CLI. Patients with well-controlled diabetes and 
uncontrolled diabetes were compared in terms of pri-
mary patency and limb salvage rates after two years. Our 
study suggests that diabetes control does not significantly 
affect primary revascularization outcomes in patients 
with CLI. This conclusion is supported by other studies 
where a strict glucose control was found to have effect 
only on patients with coronary artery disease [32, 33, 
34]. Nevertheless, as routine HbA1 level monitoring was 
introduced to our hospital only in 2005, patient num-
bers are low and strict conclusions should not be drawn.
Our study has few drawbacks. Firstly, patients with 
Type 1 diabetes mellitus were not included in this study as 
very few of them were treated in our hospital (according 
to patient history data). Secondly, comparison between 
patients with well controlled diabetes and uncontrolled 
diabetes was made in a modest group of diabetics.
Conclusions 
Both infrapopliteal angioplasty and bypass surgery 
provide an acceptable limb salvage rate, but the follow 
up patency appears to be better after bypass surgery. 
DP bypass is a safe and durable procedure in patients 
with CLI and diabetes mellitus. The duration of revas-
cularization effect was longer in the open repair group 
as compared to the endovascular repair group. The best 
revascularization results were achieved in diabetic pa-
tients after combined treatment. Endovascular therapy 
may be preferred in patients with a reduced life expec-
tancy, also for those who lack a suitable vein for bypass 
or who are at a higher risk for operation. No significant 
differences in primary revascularization outcomes were 
found between patients with well controlled and un-
controlled diabetes mellitus.
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